Cargando…
Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
Despite the clinical benefits of lowering levels of low-density lipoprotein cholesterol, many patients continue to experience cardiovascular events. This residual risk suggests that additional risk factors require aggressive modification to result in more effective prevention of cardiovascular disea...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378876/ https://www.ncbi.nlm.nih.gov/pubmed/25848301 http://dx.doi.org/10.2147/VHRM.S40134 |